Joseph P. Elliott

Results of lower extremity amputations in patients with end-stage renal disease

PURPOSE The purpose of this study was to determine the impact of end-stage renal disease (ESRD) on the outcome of patients undergoing lower extremity (LE) amputation. METHODS Hospital charts and vascular surgery registry data were reviewed for all patients who underwent LE amputation over a consecutive 56-month period. The results of 84 patients with ESRD (137 amputations) were compared with 375 patients (442 amputations) without ESRD. RESULTS Hospital mortality rate was significantly greater in patients with ESRD than patients without ESRD, 24% versus 7% (p = 0.001). Patients with ESRD undergoing minor amputations had mortality rates three times greater than patients without ESRD undergoing major LE amputations. In patients with ESRD requiring bilateral or unilateral above-knee amputation hospital mortality rates were 43% and 38%, respectively. In addition, patients with ESRD were seven times more likely to undergo bilateral amputation than patients without ESRD over a mean follow-up period of 17 months. No kidney transplant patients died after amputation. CONCLUSION ESRD has a profound negative impact on morbidity, mortality, and survival rates after LE amputation. Attempts at prevention of amputation with aggressive foot care and patient education in this high-risk group should be the focus of therapy.

Groin lymphatic complications after arterial reconstruction

PURPOSE The purpose of this study was to better define the associated risks and optimal management of groin lymphatic complications (GLC) after femoral artery reconstructive operations. METHODS Retrospective review of a vascular surgery registry for the last 15 years identified 2679 arterial operations requiring a groin incision. Forty-one GLC were recognized, 28 lymphocutaneous fistulas (LF) and 13 lymphoceles. RESULTS The incidence of GLC was 1.5% per patient or 1.2% per incision. The highest incidence of GLC was in patients having an aortobifemoral bypass for aneurysmal disease in a previously operated groin (8.1% per patient) and in those undergoing an isolated femoral procedure in a previously operated groin (5.3%). The lowest frequency of GLC was after femoropopliteal/tibial bypasses (0.5%). Twenty-nine patients (71%) were treated without operation with bedrest, intravenous antibiotics, and aggressive local wound care. Operative therapy with wound reexploration attempted identification and control of the leak site, and meticulous wound closure was used in 12 patients (29%). Lymph fistulas in patients undergoing reoperation (10/28) resolved sooner than in patients treated without operation (18/28) (9 +/- 3 days vs 24 +/- 3 days). Infectious wound complications with one resultant graft infection developed in five of 18 patients with LF who did not undergo reoperation. There were no wound or graft infections in the patients in the LF group treated with operation. Operative exploration of lymphoceles did not reduce hospital stay or infectious wound complications. Repetitive lymphocele aspiration did not affect rapidity of resolution or increase the infectious complications. CONCLUSION GLC remain a troublesome complication of femoral arterial reconstruction. Early reoperation should be performed once a LF is diagnosed. Treatment for lymphoceles should be individualized, with neither operative nor nonoperative management showing clear superiority.

Secondary Arterial Repair: The Management of Late Failures in Reconstructive Arterial Surgery

The incidence and success of secondary operations after reconstructive arterial surgery were studied in a series of 4,247 cases of aneurysmal and occlusive arterial disease. Postoperative complications requiring secondary operations occurred, in order of frequency, as the result of defective healing (including infection), deterioration of the arterial implant, and degenerative arterial changes in the site of surgical intervention. A large variety of surgical techniques were used for correction, such as total replacement, segmental resection and replacement, remote bypass, thrombectomy, and partial excision and reanastomosis. Wth the exception of complications due to infection, the results of repair were good in 60% to 90% of the various categories; only 40% of the infected grafts could be managed without the loss of life or limb. The results appear to justify the trend noted in recent years to a more aggressive use of secondary, salvage operations.

Recurrent femoral anastomotic aneurysms: a 30-year experience

Of the 1771 patients who underwent aortofemoral bypass grafting (AFB) during the 30-year period of 1957–1986, 43 noninfected recurrent femoral anastomotic aneurysms (RFAA) developed in 28 patients. Thirty-six RFAAs were treated surgically, with one death and no amputations occurring. Seven small RFAAs (<2.0 cm) were treated expectantly without complications. Using univariate and multivariate analyses, clinical characteristics and other factors influencing results in patients with RFAAs were compared to two control groups: patients who had undergone AFB without the development of femoral anastomotic aneurysms (FAAs) and patients who had undergone FAA repairs but without recurrence of FAA. Comparative analyses suggested: 1) local wound complications after initial AFB or FAA repair increased risk of a RFAA (p < 0.03); 2) development of an FAA within 4.5 years after AFB increased risk of a RFAA (p < 0.0002); 3) following an FAA repair, risk of a RFAA was almost three times greater for women than for men (p < 0.05); and 4) patients with arteriosclerotic heart disease (ASHD) were less likely to develop RFAA than those without ASHD (p < 0.05). Among the 20 additional variables analyzed—including hypertension, smoking, diabetes mellitus, and etiology of primary vascular disease—no statistically significant influence on the development of RFAAs could be detected.